CORBF
Price
$1.45
Change
-$0.05 (-3.33%)
Updated
Jul 1 closing price
Capitalization
154M
STRR
Price
$1.96
Change
+$0.01 (+0.51%)
Updated
Jul 3 closing price
Capitalization
14.07M
Interact to see
Advertisement

CORBF vs STRR

Header iconCORBF vs STRR Comparison
Open Charts CORBF vs STRRBanner chart's image
Global Cord Blood
Price$1.45
Change-$0.05 (-3.33%)
Volume$24.67K
Capitalization154M
Star Equity Holdings
Price$1.96
Change+$0.01 (+0.51%)
Volume$2.25K
Capitalization14.07M
CORBF vs STRR Comparison Chart in %
Loading...
CORBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CORBF vs. STRR commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORBF is a Hold and STRR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CORBF: $1.50 vs. STRR: $1.96)
Brand notoriety: CORBF and STRR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CORBF: 116% vs. STRR: 7%
Market capitalization -- CORBF: $154M vs. STRR: $14.07M
CORBF [@Medical Specialties] is valued at $154M. STRR’s [@Medical Specialties] market capitalization is $14.07M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORBF’s FA Score shows that 1 FA rating(s) are green whileSTRR’s FA Score has 1 green FA rating(s).

  • CORBF’s FA Score: 1 green, 4 red.
  • STRR’s FA Score: 1 green, 4 red.
According to our system of comparison, CORBF is a better buy in the long-term than STRR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORBF’s TA Score shows that 4 TA indicator(s) are bullish while STRR’s TA Score has 2 bullish TA indicator(s).

  • CORBF’s TA Score: 4 bullish, 3 bearish.
  • STRR’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CORBF is a better buy in the short-term than STRR.

Price Growth

CORBF (@Medical Specialties) experienced а 0.00% price change this week, while STRR (@Medical Specialties) price change was +1.55% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORBF($154M) has a higher market cap than STRR($14.1M). CORBF YTD gains are higher at: 0.000 vs. STRR (-13.274).
CORBFSTRRCORBF / STRR
Capitalization154M14.1M1,092%
EBITDAN/A-1.69M-
Gain YTD0.000-13.274-
P/E Ratio1.99N/A-
RevenueN/A45.8M-
Total CashN/A23.2M-
Total DebtN/A3.61M-
FUNDAMENTALS RATINGS
CORBF vs STRR: Fundamental Ratings
CORBF
STRR
OUTLOOK RATING
1..100
502
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6396
PRICE GROWTH RATING
1..100
3785
P/E GROWTH RATING
1..100
261
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CORBF's Valuation (62) in the Medical Or Nursing Services industry is somewhat better than the same rating for STRR (98) in the Medical Specialties industry. This means that CORBF’s stock grew somewhat faster than STRR’s over the last 12 months.

CORBF's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as STRR (100) in the Medical Specialties industry. This means that CORBF’s stock grew similarly to STRR’s over the last 12 months.

CORBF's SMR Rating (63) in the Medical Or Nursing Services industry is somewhat better than the same rating for STRR (96) in the Medical Specialties industry. This means that CORBF’s stock grew somewhat faster than STRR’s over the last 12 months.

CORBF's Price Growth Rating (37) in the Medical Or Nursing Services industry is somewhat better than the same rating for STRR (85) in the Medical Specialties industry. This means that CORBF’s stock grew somewhat faster than STRR’s over the last 12 months.

STRR's P/E Growth Rating (1) in the Medical Specialties industry is in the same range as CORBF (26) in the Medical Or Nursing Services industry. This means that STRR’s stock grew similarly to CORBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORBFSTRR
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CORBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSGZX16.300.18
+1.12%
MassMutual Small Cap Gr Eq I
PMVFX25.870.17
+0.66%
PGIM Quant Solutions Mid-Cap Val R4
IFPUX21.800.13
+0.60%
Independent Franchise Partners US Equity
SHPAX19.300.10
+0.52%
Saratoga Health & Biotechnology A
OAZBX37.470.06
+0.16%
Oakmark Equity and Income R6

CORBF and

Correlation & Price change

A.I.dvisor tells us that CORBF and STRR have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CORBF and STRR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORBF
1D Price
Change %
CORBF100%
N/A
STRR - CORBF
11%
Poorly correlated
+0.51%
ABT - CORBF
10%
Poorly correlated
+0.25%
IDXX - CORBF
5%
Poorly correlated
+0.79%
UFPT - CORBF
5%
Poorly correlated
+1.52%
PHG - CORBF
1%
Poorly correlated
-1.43%
More

STRR and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRR has been closely correlated with CATX. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRR jumps, then CATX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRR
1D Price
Change %
STRR100%
+0.51%
CATX - STRR
81%
Closely correlated
+8.55%
RBOT - STRR
45%
Loosely correlated
+3.40%
BJDX - STRR
38%
Loosely correlated
+0.62%
NSYS - STRR
29%
Poorly correlated
-7.38%
NVYTF - STRR
26%
Poorly correlated
N/A
More